[Source: US National Library of Medicine, full page: (LINK). Abstract, edited.]
Zhonghua Jie He He Hu Xi Za Zhi, 43 (0), E015 2020 Feb 16 [Online ahead of print]
Conventional Respiratory Support Therapy for Severe Acute Respiratory Infections (SARI): Clinical Indications and Nosocomial Infection Prevention and Control
[Article in Chinese]
Critical care committee of Chinese Association of Chest Physician, Respiratory and critical care group of Chinese Thoracic Society, Respiratory care group of Chinese Thoracic Society
PMID: 32061199 DOI: 10.3760/cma.j.issn.1001-0939.2020.0015
Abstract in English , Chinese
Severe acute respiratory infection (SARI) diseases (such as SARS, MERS, pH1N1) can rapidly progress to acute respiratory failure with high lethality. The outbreak of a novel coronavirus infection can lead to 15% ~ 30% patients developing into acute respiratory distress syndrome (ARDS). Respiratory support is the most important therapy for SARI patients with respiratory failure. However, respiratory support is a high skilled technology, which means inappropriate application may bring related complications and cross infection of SARI pathogens among medical staff and non-medical personnel in hospital. Therefore, it is meaningful to established a standardized indication of respiratory support and to prevent related nosocomial transmission in SARI patients.
Keywords: High Flow Nasal Cannula; Noninvasive positive pressure ventilation; Novel Coronavirus Pneumonia; Respiratory support; Severe Acute Respiratory Infections.
–
Keywords: SARS-CoV-2; COVID-19; SARI; ARDS.
—–
ETIDIoH 